Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
#:"(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)"
(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Dondorp%2C+Arjen+M%22&type=Person&filter%5B%5D=%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29
/vufind/Search/Results?lookfor=%22Dondorp%2C+Arjen+M%22&type=Person&filter%5B%5D=%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29
Search /vufind/Search2/Results?lookfor=%22Dondorp%2C+Arjen+M%22&type=Person&filter%5B%5D=%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29
PubPharm (22)
1
Pharmacometric assessment of the
in vivo
antiviral activity of ivermectin in early symptomatic COVID-19
enthalten in:
bioRxiv.org
| 2024
von
Schilling, W.
|
Jittamala, P.
|
Watson, J.
| +34
Wird geladen...
2
Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV)
enthalten in:
bioRxiv.org
| 2024
von
Wongnak, P.
|
Schilling, W.
|
Jittamala, P.
| +23
Wird geladen...
3
Antiviral efficacy of fluoxetine in early symptomatic COVID-19: an open-label, randomised, controlled, adaptive platform trial (PLATCOV)
enthalten in:
bioRxiv.org
| 2024
von
Jittamala, P.
|
Boyd, S.
|
Schilling, W.
| +40
Wird geladen...
4
Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open- label, randomised, controlled adaptive platform trial
enthalten in:
ResearchSquare.com
| 2024
von
Luvira, V.
|
Schilling, W.
|
Jittamala, P.
| +32
Wird geladen...
5
Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV) : an open-label, randomised, controlled, adaptive platform trial
enthalten in:
BMC infectious diseases
| 2024
von
Luvira, V.
|
Schilling, W.
|
Jittamala, P.
| +33
Wird geladen...
6
Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial
enthalten in:
BMC infectious diseases
| 2024
von
Luvira, V.
|
Schilling, W.
|
Jittamala, P.
| +32
Wird geladen...
7
Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV) : an open-label, phase 2, randomised, controlled, adaptive trial
enthalten in:
The Lancet. Infectious diseases
| 2024
von
Schilling, W.
|
Jittamala, P.
|
Watson, J.
| +89
ErratumIn: Lancet Infect Dis. 2023 Dec;23(12):e511. - PMID 37839427
Wird geladen...
8
Clinical Antiviral Efficacy of Remdesivir in Coronavirus Disease 2019 : An Open-Label, Randomized Controlled Adaptive Platform Trial (PLATCOV)
enthalten in:
The Journal of infectious diseases
| 2023
von
Jittamala, P.
|
Schilling, W.
|
Watson, J.
| +81
Wird geladen...
9
Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV)
enthalten in:
eLife
| 2023
von
Schilling, W.
|
Jittamala, P.
|
Watson, J.
| +36
Wird geladen...
10
Clinical antiviral efficacy of remdesivir and casirivimab/imdevimab against the SARS-CoV-2 Delta and Omicron variants
enthalten in:
bioRxiv.org
| 2022
von
Jittamala, P.
|
Schilling, W.
|
Watson, J.
| +39
Wird geladen...
1
2
3
Nächster »
[3]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Filter aufheben
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
22
Aufsätze
22
E-Artikel
22
E-Ressourcen
Zeitschriftentitel
7
The American journal of tropical medicine and h...
5
bioRxiv.org
2
BMC infectious diseases
1
JMIR Public Health and Surveillance
1
JMIR public health and surveillance
1
ResearchSquare.com
1
The Journal of infectious diseases
1
The Lancet. Infectious diseases
1
The Lancet. Respiratory medicine
1
Wellcome open research
1
eLife
Alle anzeigen ...
weniger ...
Thema
11
Journal Article
5
570
5
Biology
5
COVID-19
4
Antiviral Agents
4
Randomized Controlled Trial
3
Editorial
3
Multicenter Study
3
Research Support, Non-U.S. Gov't
3
SARS-CoV-2
2
3QKI37EEHE
2
Antiviral efficacy
2
Comment
2
Early treatment
2
Favipiravir
2
O3J8G9O825
2
Pharmacometrics
2
Ritonavir
2
remdesivir
1
2494G1JF75
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
7
2024
2
2023
3
2022
4
2021
6
2020
Alle anzeigen ...
weniger ...
Erscheinungsjahr(e)
Von:
Bis:
Sprache
22
Englisch
Haven't found what you're looking for?
Wird geladen...